Drugs / KLH (keyhole limpet hemocyanin)- pulsed DC (dendritic cells)
KLH (keyhole limpet hemocyanin)- pulsed DC (dendritic cells)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00843830 | Oct 2006 → Dec 2008 | carcinoma | University of Michigan Rogel Cancer Center | Terminated | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KLH (keyhole limpet hemocyanin)- pulsed DC (dendritic cells) | “Three intra-tumoral injections of 1 ml cell suspensions of KLH (keyhole limpet hemocyanin)- pulsed DC (dendritic cells) will be delivered percutaneously under ultrasound into a...” NCT00843830 ↗ |
| Modality | Vaccine | “investigational vaccine that consists of dendritic cells” NCT00843830 ↗ |
| Route | Other | “Three intra-tumoral injections of 1 ml cell suspensions of KLH (keyhole limpet hemocyanin)- pulsed DC (dendritic cells) will be delivered percutaneously under ultrasound into a...” NCT00843830 ↗ |